Therapeutic targeting of endosomal GTP-binding (G protein)-coupled receptors (GPCRs) is a novel means of drug delivery that may offer more effective and selective treatment for chronic pain and possibly other conditions, a study by Australian researchers at Monash University in Melbourne has concluded.